Using New Metabolic Approaches to Target and Eradicate Cancer Stem Cells

177.5K
views
52
authors
14
articles
Editors
3
Impact
Loading...
25,783 views
59 citations
Review
15 May 2020
Proline Metabolism in Tumor Growth and Metastatic Progression
Cristina D'Aniello
2 more and 
Gabriella Minchiotti

Cancer cells show a formidable capacity to survive under stringent conditions, to elude mechanisms of control, such as apoptosis, and to resist therapy. Cancer cells reprogram their metabolism to support uncontrolled proliferation and metastatic progression. Phenotypic and functional heterogeneity are hallmarks of cancer cells, which endow them with aggressiveness, metastatic capacity, and resistance to therapy. This heterogeneity is regulated by a variety of intrinsic and extrinsic stimuli including those from the tumor microenvironment. Increasing evidence points to a key role for the metabolism of non-essential amino acids in this complex scenario. Here we discuss the impact of proline metabolism in cancer development and progression, with particular emphasis on the enzymes involved in proline synthesis and catabolism, which are linked to pathways of energy, redox, and anaplerosis. In particular, we emphasize how proline availability influences collagen synthesis and maturation and the acquisition of cancer cell plasticity and heterogeneity. Specifically, we propose a model whereby proline availability generates a cycle based on collagen synthesis and degradation, which, in turn, influences the epigenetic landscape and tumor heterogeneity. Therapeutic strategies targeting this metabolic-epigenetic axis hold great promise for the treatment of metastatic cancers.

31,734 views
114 citations
Case Report
05 May 2020
Managing Metastatic Thymoma With Metabolic and Medical Therapy: A Case Report
Matthew C. L. Phillips
2 more and 
Ben G. Moon
Article Cover Image

Thymomas consist of neoplastic thymic cells intermixed with variable numbers of non-neoplastic lymphocytes. Metastatic thymomas are typically managed with non-curative chemotherapy to control tumor-related symptoms; no prolonged survival is expected. Metabolic-based approaches, such as fasting and ketogenic diets, target cancer cell metabolism by creating an increased reliance on ketones while decreasing glucose, glutamine, and growth factor availability, theoretically depriving cancer cells of their metabolic fuels while creating an unfavorable environment for cancer growth, which may be beneficial in metastatic thymoma. We report the case of a 37-year-old woman with myasthenia gravis, diagnosed with an inoperable type AB, stage IVA thymoma, who pursued a metabolic intervention consisting of periodic fasting (7-day, fluid-only fasts every 1–2 months), combined with a modified ketogenic diet on feeding days, for 2 years. Fasting-related adverse effects included cold intolerance, fatigue, and generalized muscle aches, all of which resolved during the second year. She experienced two myasthenia relapses, each associated with profoundly reduced oral intake, marked weight loss, and tumor regression-the first relapse was followed by a 32% decrease in tumor volume over 4 months, the second relapse by a dramatic 96% decrease in tumor volume over 4 months. The second relapse also required prednisone to control the myasthenia symptoms. We hypothesize that 2 years of fasting and ketogenic diet therapy metabolically weakened the neoplastic thymic cell component of the thymoma, “setting the stage” for immune activation and extreme energy restriction to destroy the majority of cancer cells during both relapses, while prednisone-induced apoptosis eradicated the remaining lymphocytic component of the thymoma during the second relapse. This case is unique in that a metabolic-based fasting and ketogenic diet intervention was used as the primary management strategy for a metastatic cancer in the absence of surgery, chemotherapy, or radiotherapy, culminating in a near-complete regression. Nearly 3 years after being diagnosed with inoperable metastatic cancer, our patient shows no signs of disease and leads a full and active life.

33,204 views
9 citations
Open for submission
Frontiers Logo

Frontiers in Oncology

Effects of Mitochondrial Dysregulation on Blood Cancer Treatment
Edited by Maria Hernandez-Valladares, Natalia V Kirienko, Natalia Baran
Deadline
25 January 2025
Submit a paper
Recommended Research Topics
Frontiers Logo

Frontiers in Oncology

Developing Combined Modality Therapy with Mitochondria-Targeting Strategy
Edited by Yong Teng, Austin Young Shull, Lixia Gao
47.3K
views
61
authors
8
articles
Frontiers Logo

Frontiers in Oncology

Metabolic Plasticity of Cancer
Edited by Tuuli Käämbre, Rafael Moreno-Sánchez, Sara Rodriguez-Enriquez
97.9K
views
87
authors
15
articles
Frontiers Logo

Frontiers in Oncology

Redox Metabolism: a Double Edge Sword Sustaining the Adaptive Resistance to Therapy in Cancer
Edited by Barbara Marengo, Cinzia Domenicotti, Jose Pedro Friedmann Angeli
20.6K
views
7
articles
Frontiers Logo

Frontiers in Oncology

Biological and Therapeutic Perspectives of Mitochondria in Cancer
Edited by Eduardo Nestor Maldonado, Stéphen Manon, Alvaro A. Elorza
20.6K
views
44
authors
6
articles